Trial date set for Trump’s legal case against BBC
Donald Trump’s multi-billion dollar lawsuit against the BBC is set to go to trial in February 2026. Image: Allen Beilschmidt sr. / Pexels Source: BBC
Donald Trump’s multi-billion dollar lawsuit against the BBC is set to go to trial in February 2026. Image: Allen Beilschmidt sr. / Pexels Source: BBC
Mark Zuckerberg. | Image: Cath Virginia / The Verge, Getty Images Image: Tim Mossholder / Unsplash At the center of a consequential case about social media liability is a key question: did Meta lie or mislead the public about the safety of its platform, while knowing something very different? The state of New Mexico opened…
Attorney general Raúl Torrez is accusing the tech giant of failing to protect minors on Facebook and Instagram. Image: Julio Lopez / Unsplash Source: Wired
Live Nation executives have reportedly sidestepped the Justice Department’s antitrust division to negotiate directly with more sympathetic senior officials in the hopes of avoiding a monopoly trial. Citing “people familiar with the matter,” Semafor reports that some talks have excluded antitrust chief Gail Slater, who has pushed for a trial to take place in March…
Introduction A Silicon Valley courtroom is set to become the unlikely arena for a battle that could shape the trajectory of artificial intelligence. On April 27th, a federal jury in Northern California will begin weighing Elon Musk’s explosive lawsuit against OpenAI, the company he helped create. This isn’t just a contractual dispute; it’s a profound…
Introduction A San Francisco courtroom is set to become the epicenter of a defining battle for the soul of artificial intelligence. Tech titan Elon Musk’s explosive lawsuit against OpenAI, the research lab he co-founded, will be decided by a jury next March. The trial promises to dissect broken promises, corporate metamorphosis, and the very future…
Compass, NWMLS Clash Over Document Production in Antitrust Suit The legal battle between real estate disruptor Compass and the Northwest Multiple Listing Service (NWMLS) has entered a contentious new phase. At the heart of the dispute is a fight over the pace of evidence sharing, with Compass accusing the listing service of deliberate delay tactics….
A revolutionary new treatment for incurable blood cancer has delivered remarkable results in early clinical trials, with seven out of 11 patients showing no signs of disease following the experimental therapy. The pioneering approach represents a potential paradigm shift in treating previously untreatable blood malignancies, offering renewed hope to thousands of patients worldwide who face…